DaSilva Jean, Decristoforo Clemens, Mach Robert H, Bormans Guy, Carlucci Giuseppe, Al-Qahtani Mohammed, Duatti Adriano, Gee Antony D, Szymanski Wiktor, Rubow Sietske, Hendrikx Jeroen, Yang Xing, Jia Hongmei, Zhang Junbo, Caravan Peter, Yang Hua, Zeevaart Jan Rijn, Rodriquez Miguel Avila, Oliveira Ralph Santos, Zubillaga Marcela, Sakr Tamer, Spreckelmeyer Sarah
University of Montreal, Montreal, Canada.
Medical University Innsbruck, Innsbruck, Austria.
EJNMMI Radiopharm Chem. 2023 Oct 27;8(1):35. doi: 10.1186/s41181-023-00218-y.
The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biannual highlight commentary to update the readership on trends in the field of radiopharmaceutical development.
This selection of highlights provides commentary on 21 different topics selected by each coauthoring Editorial Board member addressing a variety of aspects ranging from novel radiochemistry to first-in-human application of novel radiopharmaceuticals.
Trends in radiochemistry and radiopharmacy are highlighted. Hot topics cover the entire scope of EJNMMI Radiopharmacy and Chemistry, demonstrating the progress in the research field in many aspects.
《EJNMMI放射药学与化学》编辑委员会每半年发布一次重点评论，向读者介绍放射性药物开发领域的趋势。
本重点内容选集对每位共同撰写的编辑委员会成员选择的21个不同主题进行了评论，涉及从新型放射化学到新型放射性药物的首次人体应用等各个方面。
突出了放射化学和放射药学的趋势。热门话题涵盖了《EJNMMI放射药学与化学》的整个范围，展示了该研究领域在许多方面的进展。
Zotero 插件
